Back to Essays

Background: Medical Knowledge Is Outpacing Physicians

* This article accompanies Medical Knowledge Is Outpacing Physicians by examining the evidence behind its central premise. Rather than presenting an opinion, it summarizes published research, statistics, and historical perspectives on whether medical knowledge is expanding faster than physicians can realistically absorb, retain, and apply.

Executive Summary

The available evidence consistently supports several broad conclusions.

  • The volume of biomedical research continues to grow at an extraordinary rate, with more than 40 million citations indexed in PubMed and approximately 1.57 million new citations added during 2023 alone (National Library of Medicine).
  • Physicians must keep pace not only with published research, but also with clinical trials, treatment guidelines, FDA approvals, medical devices, genetics, diagnostics, and safety updates.
  • Concerns about “medical knowledge overload” have existed for decades and have been documented repeatedly in the medical literature (PubMed).
  • Research findings often take years to become part of routine clinical practice, and many clinical trials do not fully represent the medically complex patients seen in everyday practice (National Academy of Medicine).
  • Healthcare organizations are responding through Learning Health Systems, real-world evidence, and AI-assisted clinical tools, recognizing that managing knowledge has become one of the defining challenges of modern medicine.

Taken together, these findings suggest that the challenge facing healthcare is no longer simply discovering new knowledge. It is ensuring that clinicians can access, evaluate, and apply the right knowledge at the right moment for the patient sitting in front of them.

1. The Volume of Medical Knowledge Is Enormous and Still Growing

The scale of modern medical knowledge is difficult to comprehend.

PubMed, maintained by the U.S. National Library of Medicine, now contains more than 40 million biomedical citations. During fiscal year 2023 alone, approximately 1.57 million new citations were added—more than 4,000 every day. MEDLINE indexed roughly 1.28 million citations from more than 5,000 biomedical journals during that same year (National Library of Medicine).

Those numbers represent only one component of the information physicians must consider.

Beyond the published literature, physicians are expected to remain current with:

  • Clinical trial results
  • Drug approvals and revised indications
  • Medical-device approvals
  • Treatment guidelines
  • Safety warnings
  • Imaging and diagnostic advances
  • Genetics and molecular medicine
  • Real-world clinical evidence

The pace of change extends well beyond academic publishing.

In 2025, the U.S. Food and Drug Administration approved 46 novel drugs and authorized 124 novel medical devices, including the first blood test authorized to assist in diagnosing Alzheimer’s disease (U.S. Food and Drug Administration). These figures exclude the many additional approvals involving expanded indications, new formulations, revised dosing recommendations, labeling changes, and incremental improvements to existing therapies.

Research is also taking place on a global scale. The World Health Organization maintains an international registry that aggregates clinical trials from participating countries, recognizing that no single institution captures the full scope of biomedical research (World Health Organization). Thousands of studies are underway at any given time, many of which will eventually influence clinical practice, treatment guidelines, or future research.

And biomedical publications represent only the beginning.

Scientific discoveries must be evaluated, replicated, incorporated into professional society guidelines, taught through continuing medical education, interpreted within the context of individual patients, and balanced against existing standards of care. The accumulation of information therefore extends well beyond simply counting published papers.

This growth is occurring across virtually every area of medicine. Advances in genomics, immunotherapy, precision medicine, artificial intelligence, neuroscience, regenerative medicine, and digital health are expanding the body of knowledge available to clinicians at an unprecedented pace. At the same time, many specialties continue to become increasingly subspecialized, making it more difficult for any one physician to maintain deep expertise across a broad range of conditions.

The result is a simple but important observation.

Every year adds another million research papers, thousands of clinical trials, new drugs, new devices, revised guidelines, updated safety information, and emerging diagnostic technologies. Even before considering the quality or clinical relevance of this information, the sheer volume represents a significant challenge for any individual physician.

2. Information Overload in Medicine Is Not a New Concern

Although artificial intelligence has recently brought renewed attention to information overload, the underlying problem is far from new.

Researchers were warning about “medical knowledge overload” among physicians as early as the 1990s (PubMed). Subsequent reviews have repeatedly documented both the growing quantity and increasing complexity of medical information, along with the challenges physicians face in converting new research into practical clinical knowledge.

Medicine has long recognized that graduation from medical school is only the beginning of a physician’s education.

Physicians rely on multiple mechanisms to remain current throughout their careers, including:

  • Medical journals
  • Continuing Medical Education (CME)
  • Professional conferences
  • Clinical practice guidelines
  • Specialist consultation
  • Professional societies

These mechanisms remain essential to modern medical practice. However, they all depend upon physicians finding, reading, evaluating, remembering, and appropriately applying relevant information while simultaneously caring for patients, managing administrative responsibilities, and keeping pace with rapidly evolving standards of care.

The American Medical Association describes continuing medical education as an essential professional responsibility. The AMA’s educational catalog includes more than 1,700 CME credit opportunities, illustrating both the profession’s commitment to lifelong learning and the extraordinary breadth of knowledge physicians are expected to maintain (American Medical Association).

Yet education alone cannot eliminate an unavoidable human limitation.

Research suggests that medical knowledge not used regularly is more likely to decline over time (PubMed). Physicians naturally become highly proficient in the conditions they encounter every day, while rare diseases, unusual complications, or uncommon combinations of medical conditions may require revisiting literature that has not been consulted for months or even years.

This distinction is important.

The challenge facing modern medicine is not that physicians fail to learn. Rather, it is that the amount of potentially relevant knowledge has grown beyond what any individual can reasonably absorb, retain, and recall over the course of a career.

That observation does not diminish the expertise of physicians. If anything, it underscores the remarkable demands placed upon them by an ever-expanding scientific landscape.

3. Discovering Something Does Not Mean It Quickly Reaches Patients

Generating new medical knowledge and applying it in routine patient care are very different processes.

A frequently cited study estimated that it takes approximately 17 years for evidence-based discoveries to become routine clinical practice (Morris et al., PubMed). Although that figure should not be interpreted as a universal rule—some breakthroughs spread far more quickly while others take considerably longer—the broader conclusion has been confirmed repeatedly: translating research into widespread clinical practice often requires many years.

This delay is not simply the result of physicians being slow to adopt new ideas.

Medical discoveries must first be independently validated, replicated by other researchers, reviewed by regulatory agencies, incorporated into professional society guidelines, taught through continuing medical education, evaluated by hospitals and healthcare systems, and ultimately accepted by practicing physicians. Each of these steps helps protect patients by ensuring that new treatments are both safe and effective before becoming standard practice.

The National Academy of Medicine has identified several reasons why this process remains challenging:

  • Much of the data generated during routine healthcare is never captured for systematic learning.
  • Clinical guidelines are sometimes based on limited-quality evidence.
  • Research findings often take years to become part of routine clinical practice.
  • Strict clinical-trial criteria frequently exclude many of the patients physicians actually treat (National Academy of Medicine).

The final point deserves particular attention.

Randomized clinical trials remain the gold standard for establishing whether a treatment works. However, they often enroll carefully selected patients in order to reduce variables that could complicate interpretation of the results. Older patients, individuals with multiple chronic illnesses, or those taking numerous medications are frequently excluded from participation.

As a result, the patients seen in everyday clinical practice may differ substantially from those represented in the published evidence.

One National Academy of Medicine review found that only 13% to 25% of real-world heart failure patients would have qualified for the clinical trials supporting their treatment recommendations. Similar limitations have been documented in asthma and numerous other medical specialties (National Academy of Medicine).

This does not diminish the value of clinical trials. Rather, it illustrates why physicians must combine scientific evidence with clinical judgment, experience, and knowledge of each patient’s individual circumstances.

Research provides the foundation for evidence-based medicine. Applying that evidence to a patient with multiple diseases, previous surgeries, genetic variations, and complex medication interactions remains one of the most demanding aspects of clinical care.

4. Healthcare Is Already Trying to Become a Continuous Learning System

The medical community has not ignored these challenges.

Over the past two decades, healthcare organizations have increasingly recognized that traditional approaches to generating and sharing knowledge are no longer sufficient for the pace of modern medicine.

One of the most significant responses has been the development of the Learning Health System, an idea championed by the National Academy of Medicine.

Rather than viewing research and patient care as separate activities, a Learning Health System seeks to create a continuous cycle in which clinical care generates new knowledge, that knowledge informs future care, and the process repeats indefinitely (National Academy of Medicine).

In this model, every patient encounter has the potential to contribute to improving healthcare—not only for the individual patient but for future patients as well.

Electronic health records, disease registries, quality improvement initiatives, clinical decision support systems, and large-scale healthcare databases all contribute to this learning process. Instead of relying exclusively on traditional clinical trials, healthcare systems increasingly analyze information generated during routine medical practice to identify trends, evaluate treatments, and improve patient outcomes.

The U.S. Food and Drug Administration has similarly expanded its use of Real-World Evidence (RWE).

Real-world evidence draws upon information collected outside traditional randomized clinical trials, including:

  • Electronic health records
  • Insurance claims
  • Disease registries
  • Medical-device data
  • Patient-generated health information

These sources allow researchers and regulators to better understand how treatments perform across broader and more diverse patient populations than are typically represented in clinical trials (U.S. Food and Drug Administration).

The FDA also maintains a public database of AI-enabled medical devices that have received regulatory authorization, reflecting the growing role of machine learning in diagnostic imaging, cardiology, pathology, radiology, ophthalmology, and many other specialties.

Taken together, these initiatives demonstrate an important point.

Healthcare is not standing still. Researchers, regulators, hospitals, and professional organizations all recognize that medical knowledge is expanding beyond the capacity of traditional methods of education and dissemination. The challenge is no longer acknowledging the problem, but building systems capable of delivering the right information to clinicians when they need it.

5. AI Is Beginning to Help, But It Has Not Solved the Problem

Artificial intelligence has emerged as one of the most promising tools for addressing medical information overload.

Unlike traditional medical reference systems, modern AI systems can rapidly synthesize information from scientific literature, clinical guidelines, laboratory results, medical imaging, electronic health records, and other sources to provide physicians with relevant information during patient care.

Already, AI is being applied across numerous areas of medicine, including:

  • Medical imaging interpretation
  • Clinical documentation
  • Literature review
  • Diagnostic decision support
  • Drug discovery
  • Risk prediction
  • Analysis of large clinical datasets

A 2025 review published by NEJM AI described how generative AI is already influencing clinical documentation, decision support, patient communication, and workflow efficiency (NEJM AI).

Evidence that AI can improve clinical reasoning is also beginning to emerge.

In one randomized study involving 92 clinicians working through complex diagnostic cases, physicians using an AI system alongside conventional resources achieved significantly better diagnostic performance than those relying solely on traditional information sources (NEJM AI).

Other reviews have highlighted AI’s ability to integrate clinical history, laboratory results, medical imaging, genomic information, and published medical literature—allowing physicians to identify relationships that would be difficult or impossible to recognize manually (New England Journal of Medicine).

Yet the medical community has been careful to emphasize that these technologies remain tools rather than replacements for physician judgment.

Recent reviews continue to identify important limitations, including:

  • AI hallucinations
  • Embedded bias within training data
  • Inconsistent performance across patient populations
  • Privacy and security concerns
  • Overreliance that could erode clinical reasoning skills

Accordingly, the emerging consensus is not that AI should replace physicians, but that it should augment them.

The physician remains responsible for interpreting the patient’s history, understanding their preferences and values, weighing competing risks, recognizing when recommendations do not fit the clinical situation, and ultimately making decisions that balance scientific evidence with human judgment.

If the defining challenge of modern medicine is information overload, AI offers a practical way to help clinicians navigate an increasingly complex body of knowledge. But like every previous medical innovation, its effectiveness will depend not only on the technology itself, but also on how thoughtfully it is integrated into clinical practice.

Common Questions

Does Medical Knowledge Really Double Every 73 Days?

One statistic appears repeatedly in discussions about healthcare, education, and artificial intelligence: medical knowledge now doubles every 73 days.

The exact figure, however, deserves some context.

Unlike population growth or financial data, “medical knowledge” is not something that can be measured directly. Researchers must first decide what counts as knowledge. Should it include every published paper? Only validated discoveries? Clinical guidelines? New therapies? Diagnostic techniques? Different definitions naturally produce different estimates.

The 73-day estimate traces back to recent analyses attempting to quantify the accelerating growth of biomedical information. Earlier studies suggested considerably longer doubling times, reflecting the fact that the pace of medical research has continued to accelerate over the past several decades.

Whether the precise number is 73 days, six months, or one year is ultimately less important than the broader trend.

The evidence reviewed throughout this article demonstrates that biomedical research continues to expand at an extraordinary pace. More than one million new PubMed citations are added annually, accompanied by thousands of clinical trials, new drugs, revised treatment guidelines, safety updates, diagnostic technologies, and advances in genetics and molecular medicine.

No individual physician is expected to read every paper or master every specialty. Instead, physicians rely on education, clinical experience, professional guidelines, consultation with colleagues, and increasingly, digital decision-support tools to determine which knowledge is relevant to the patients they treat.

The precise doubling rate therefore should not become the central debate.

The more important observation is that medically relevant information is expanding far faster than traditional methods of education and information management were designed to accommodate. Regardless of the exact doubling interval, the underlying challenge remains the same: helping physicians access the right knowledge at the right time.

Are Humans Really Going to Live to 120–150 Years?

Another frequently cited prediction is that advances in biotechnology and artificial intelligence may soon allow humans to live routinely to 120 or even 150 years.

Such claims have attracted increasing attention from researchers, biotechnology companies, and the media.

Some scientists believe that rapid advances in genetics, regenerative medicine, AI-assisted drug discovery, cellular reprogramming, and personalized medicine could dramatically extend healthy human lifespan during this century. Nature has examined research suggesting that, under certain theoretical assumptions, the body’s biological resilience may extend into the 120–150-year range (Nature).

Other researchers are considerably more cautious.

Recent analyses published in Nature Aging argue that dramatic life extension remains unlikely within the foreseeable future and that current evidence continues to support a practical upper limit to human lifespan near 125 years (Nature Aging). Likewise, predictions that many major diseases will be cured within the next decade remain informed forecasts rather than established scientific conclusions.

The purpose of raising these debates is not to predict how long humans will ultimately live.

Rather, they illustrate the extraordinary breadth and ambition of modern biomedical research. Scientists are simultaneously investigating aging, Alzheimer’s disease, cancer, gene editing, regenerative medicine, precision therapeutics, immunology, neuroscience, synthetic biology, and countless other fields.

Every meaningful advance contributes another piece to the expanding body of medical knowledge that clinicians must understand, interpret, and apply.

Whether or not today’s longevity predictions eventually prove correct, they demonstrate that medicine is entering an era in which scientific discovery is accelerating across multiple disciplines at once.

Evidence Summary

The published evidence consistently supports one overarching conclusion: medical knowledge is expanding at an unprecedented rate.

Researchers have documented the extraordinary growth of biomedical literature, the increasing complexity of clinical practice, the delays involved in translating research into routine patient care, and the challenges physicians face when applying evidence to medically complex patients.

Healthcare has responded in meaningful ways.

Medical schools emphasize lifelong learning. Professional societies continually update clinical guidelines. Healthcare organizations are developing Learning Health Systems that transform routine patient care into opportunities for continuous improvement. Regulatory agencies increasingly incorporate real-world evidence into their evaluations. Artificial intelligence is beginning to assist physicians by rapidly organizing and synthesizing vast amounts of medical information.

These developments all point to the same underlying reality.

The challenge facing modern medicine is no longer simply generating new knowledge. It is ensuring that clinically relevant knowledge reaches physicians quickly enough, in a form they can trust, and at the moment it is needed to improve patient care.

Individual claims—such as medical knowledge doubling every 73 days or humans routinely living to 150 years—may continue to evolve as new evidence emerges. They should be viewed as illustrations of a broader trend rather than as the central argument.

That broader trend is difficult to dispute.

The quantity and complexity of biomedical knowledge now exceed what any individual physician can reasonably absorb, retain, and recall over the course of a career using traditional approaches alone.

For generations, the defining challenge of medicine was discovering new knowledge.

Increasingly, the defining challenge is ensuring that the right knowledge reaches the right physician at the right time, so that every patient can benefit from the best evidence available.

References

Picture of Max Sigma

Max Sigma

Vik Kachoria ("Max") writes about leadership, technology, institutions, incentives, and the ideas shaping the future of society. He is the Founder & CEO of Spike Aerospace and the creator of MaxSigma.
Articles
On this page

Also of Interest

Ideas worth your time.

Essays on technology, leadership, society, and the future.

Share the Essay

X-twitter Linkedin Rss